High-Quality Veterinary Medicine API Lincomycin HCl CAS 859-18-7 with GMP

Product Details
Customization: Available
Varieties: General Disease Prevention Medicine
Component: Chemical Synthetic Drugs
Still deciding? Get samples of US$ 50/kg
Request Sample
Manufacturer/Factory & Trading Company

360° Virtual Tour

Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Number of Employees
360
Year of Establishment
2004-06-18
  • High-Quality Veterinary Medicine API Lincomycin HCl CAS 859-18-7 with GMP
  • High-Quality Veterinary Medicine API Lincomycin HCl CAS 859-18-7 with GMP
  • High-Quality Veterinary Medicine API Lincomycin HCl CAS 859-18-7 with GMP
  • High-Quality Veterinary Medicine API Lincomycin HCl CAS 859-18-7 with GMP
  • High-Quality Veterinary Medicine API Lincomycin HCl CAS 859-18-7 with GMP
  • High-Quality Veterinary Medicine API Lincomycin HCl CAS 859-18-7 with GMP
Find Similar Products

Basic Info.

Model NO.
API Powder
Type
The First Class
Pharmacodynamic Influential Factors
Combined Medication
Storage Method
Prevent ThrowIing Expired Veterinary Drugs
Characters
off-White Crystalline Powder
pH
3.2-5.4
Water
3.1% - 5.8%
Assay
Not Less Than 790ug/Mg
Heavy Metals
Less Than 20 Ppm
Standard
USP
Transport Package
Carton
Specification
1kg/bag; 25kg/drum
Trademark
Moosun
Origin
China
HS Code
2941904000

Product Description

Product description

Product name Lincomycin hydrochloride 
Appearance Off-white crystalline powder
CAS 859-18-7
EINECS 212-726-7

Lincomycin hydrochloride Introduction

Lincomycin hydrochloride is a semi-synthetic chlorinated derivative of lincomycin and is indicated for the treatment of various infectious diseases caused by gram-positive and anaerobic bacteria and also for the treatment of infections caused by methicillin-resistant Staphylococcus aureus.
Application:
1. Oral formulations is suitable for treating respiratory infections, abdominal infection, female reproductive tract infections, pelvic infections, skin and soft tissue infections caused by sensitive Staphylococcus aureus and Streptococcus pneumoniae. 
2. In addition to the treatment of the above infections, injected formulations are suitable for treatment of severe infections caused by streptococcus, pneumococcus and staphylococcus such as the surgical adjuvant therapy of septicemia, bone and joint infections, chronic bone and joint infections and Staphylococcus-induced acute hematogenous osteomyelitis. 
3. Lincomycin hydrochloride may also be used for the treatment of infectious diseases in patients allergic to penicillin or not suitable for administration of penicillin-type drugs.
Certificate of Analysis
High-Quality Veterinary Medicine API Lincomycin HCl CAS 859-18-7 with GMP
Company Profile
High-Quality Veterinary Medicine API Lincomycin HCl CAS 859-18-7 with GMP

 
Our Team
High-Quality Veterinary Medicine API Lincomycin HCl CAS 859-18-7 with GMP
 
 
Office & Factory 
High-Quality Veterinary Medicine API Lincomycin HCl CAS 859-18-7 with GMP
 
 
Our Certificates
High-Quality Veterinary Medicine API Lincomycin HCl CAS 859-18-7 with GMP
 
Advanced production equipment
 
High-Quality Veterinary Medicine API Lincomycin HCl CAS 859-18-7 with GMP
 
 
 
Quality Control 
High-Quality Veterinary Medicine API Lincomycin HCl CAS 859-18-7 with GMP
 
 
Stock and Shipping
High-Quality Veterinary Medicine API Lincomycin HCl CAS 859-18-7 with GMP
 
Our Customers
High-Quality Veterinary Medicine API Lincomycin HCl CAS 859-18-7 with GMP
 
 
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier